Gsk Plc's Suppliers recorded an increase in sales by 35.39 % year on year in Q4 2025, sequentially sales grew by 37.3 %, while their net margin rose to 12.51 % year on year, Gsk Plc's Suppliers improved sequentially profit margin to 37.3 %,
Gsk Plc's Suppliers recorded an increase in sales by 35.39 % year on year in Q4 2025, sequentially sales grew by 37.3 %, while their net margin rose to 12.51 % year on year, Gsk Plc's Suppliers improved sequentially profit margin to 12.51 %,
GSK manufactures medicines and vaccines using raw materials with a focus on sustainable sourcing and water stewardship. By 2023, the company achieved 100% good water stewardship at its sites and reduced overall water use by 30% since 2020. GSK operates in water-stressed basins in Algeria, India, and Pakistan, collaborating with co-located suppliers to set water targets and reduce water use by 19% since 2020. The company partnered with WWF to protect and restore freshwater ecosystems in India and Pakistan. By 2025, GSK aims for all sites and key suppliers to meet predicted no effect concentrations (PNECs) for active pharmaceutical ingredients in the environment. Additionally, GSK targets positive biodiversity impact at all owned sites by 2030, with sites such as Stevenage, Zebulon, and Wavre implementing biodiversity net gain plans. GSK engages specific suppliers in water stewardship and active pharmaceutical ingredient discharge compliance. The company works with organizations including the Alliance for Water Stewardship, AMR Industry Alliance, Science Based Target Network, Taskforce for Nature-related Financial Disclosures, and WWF.
Gsk Plc's Comment on Supply Chain
GSK manufactures medicines and vaccines using raw materials with a focus on sustainable sourcing and water stewardship. By 2023, the company achieved 100% good water stewardship at its sites and reduced overall water use by 30% since 2020. GSK operates in water-stressed basins in Algeria, India, and Pakistan, collaborating with co-located suppliers to set water targets and reduce water use by 19% since 2020. The company partnered with WWF to protect and restore freshwater ecosystems in India and Pakistan. By 2025, GSK aims for all sites and key suppliers to meet predicted no effect concentrations (PNECs) for active pharmaceutical ingredients in the environment. Additionally, GSK targets positive biodiversity impact at all owned sites by 2030, with sites such as Stevenage, Zebulon, and Wavre implementing biodiversity net gain plans. GSK engages specific suppliers in water stewardship and active pharmaceutical ingredient discharge compliance. The company works with organizations including the Alliance for Water Stewardship, AMR Industry Alliance, Science Based Target Network, Taskforce for Nature-related Financial Disclosures, and WWF.
GSK's Suppliers Net Income grew by
GSK's Suppliers Net margin grew in Q4 to
72.6 %
12.51 %
GSK's Suppliers Net Income grew by 72.6 %
GSK's Suppliers Net margin grew in Q4 to 12.51 %
Gsk Plc's Suppliers Sales Growth
in Q4 2025 by Industry
Sources:
Gsk Plc's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Gsk Plc’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
